(Q33970997)

30 July 2017

1 reference

title

DNA vaccines: a key for inducing long-term cellular immunity (English)

1 reference

30 July 2017

Gurunathan S

1

1 reference

30 July 2017

Wu CY

series ordinal

2

1 reference

30 July 2017

Freidag BL

series ordinal

3

1 reference

30 July 2017

Seder RA

series ordinal

4

1 reference

30 July 2017

publication date

1 August 2000

1 reference

Current Opinion in Immunology

30 July 2017

published in

1 reference

30 July 2017

volume

12

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

442-447

1 reference

DNA vaccines: immunology, application, and optimization*

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Pervasive CpG suppression in animal mitochondrial genomes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

DNA methylation and its possible biological roles

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Therapeutic applications of CpG-containing oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Activation of human B cells by phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

DNA vaccination: transfection and activation of dendritic cells as key events for immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Cytotoxic T lymphocytes against a soluble protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Heat shock protein 70-associated peptides elicit specific cancer immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Vaccination against tuberculosis by DNA injection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

Therapy of tuberculosis in mice by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900118-7

7 January 2021

10.1016/S0952-7915(00)00118-7

Identifiers

DOI

1 reference

30 July 2017

1 reference